Not sure I agree, Bourbon. When the tutes bought in at 19, including Adage, the stock still had alot of upward momentum. I would say that speculators and traders were more to blame for the rise to 30; upward manipulation was not really even necessary. I think some of the tutes, including Adage, decided to short their own shares when the news leaked about the impending FDA hold. Plus, of course, many naked shorts, mainly hedgies and mm's. I still believe that this whole short attack started in earnest when certain parties got notice of the FDA hold (or the possibility of it, meaning the fact of the patient death) well in advance. Of course there was shorting prior to that; it's a clinical biotech. But the hold is what prompted this long and abusive short scheme.